<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immun.</journal-id>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immun.</abbrev-journal-title>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Research Foundation</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2011.00005</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>A Conserved Hydrophobic Patch on V&#x003B2; Domains Revealed by TCR&#x003B2; Chain Crystal Structures: Implications for Pre-TCR Dimerization</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Zhou</surname> <given-names>Bo</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Chen</surname> <given-names>Qiang</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Mallis</surname> <given-names>Robert J.</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Zhang</surname> <given-names>Hongmin</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Liu</surname> <given-names>Jin-huan</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Reinherz</surname> <given-names>Ellis L.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Wang</surname> <given-names>Jia-huai</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="aff" rid="aff5"><sup>5</sup></xref>
<xref ref-type="author-notes" rid="fn001">&#x0002A;</xref>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Laboratory of Immunobiology, Dana-Farber Cancer Institute, Harvard Medical School</institution> <country>Boston, MA, USA</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Medicine, Harvard Medical School</institution> <country>Boston, MA, USA</country></aff>
<aff id="aff3"><sup>3</sup><institution>Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School</institution> <country>Boston, MA, USA</country></aff>
<aff id="aff4"><sup>4</sup><institution>Department of Physiology, The University of Hong Kong</institution> <country>Hong Kong, China</country></aff>
<aff id="aff5"><sup>5</sup><institution>Department of Pediatrics, Harvard Medical School</institution> <country>Boston, MA, USA</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Michael Dustin, New York University, USA</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Balbino Alarcon, Superior Council for Scientific Research, Spain; Roy Mariuzza, University of Maryland, USA; Christopher Garcia, Stanford University, USA</p></fn>
<fn fn-type="corresp" id="fn001"><p>&#x0002A;Correspondence: Dana-Farber Cancer Institute, 44 Binney Street, SM 1030, Boston, MA 02115, USA. e-mail: <email>jwang&#x00040;red.dfci.harvard.edu</email></p></fn>
<fn fn-type="other" id="fn002"><p>This article was submitted to Frontiers in T Cell Biology, a specialty of Frontiers in Immunology.</p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>01</day>
<month>03</month>
<year>2011</year>
</pub-date>
<pub-date pub-type="collection">
<year>2011</year>
</pub-date>
<volume>2</volume>
<elocation-id>5</elocation-id>
<history>
<date date-type="received">
<day>06</day>
<month>01</month>
<year>2011</year>
</date>
<date date-type="accepted">
<day>15</day>
<month>02</month>
<year>2011</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2011 Zhou, Chen, Mallis, Zhang, Liu, Reinherz and Wang.</copyright-statement>
<copyright-year>2011</copyright-year>
<license license-type="open-access" xlink:href="http://www.frontiersin.org/licenseagreement"><p>This is an open-access article subject to an exclusive license agreement between the authors and Frontiers Media SA, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are credited.</p></license>
</permissions>
<abstract>
<p>The &#x003B1;&#x003B2; T cell receptor (TCR) is a multimeric complex whose &#x003B2; chain plays a crucial role in thymocyte development as well as antigen recognition by mature T lymphocytes. We report here crystal structures of individual &#x003B2; subunits, termed N15&#x003B2; (V&#x003B2;5.2D&#x003B2;2J&#x003B2;2.6C&#x003B2;2) and N30&#x003B2; (V&#x003B2;13D&#x003B2;1J&#x003B2;1.1C&#x003B2;2), derived from two &#x003B1;&#x003B2; TCRs specific for the immunodominant vesicular stomatitis virus octapeptide (VSV-8) bound to the murine H-2K<sup>b</sup> MHC class I molecule. The crystal packing of the N15&#x003B2; structure reveals a homodimer formed through two V&#x003B2; domains. The V&#x003B2;/V&#x003B2; module is topologically very similar to the V&#x003B1;/V&#x003B2; module in the N15&#x003B1;&#x003B2; heterodimer. By contrast, in the N30&#x003B2; structure, the V&#x003B2; domain&#x02019;s external hydrophobic CFG face is covered by the neighboring molecule&#x02019;s C&#x003B2; domain. In conjunction with systematic investigation of previously published TCR single-subunit structures, we identified several conserved residues forming a concave hydrophobic patch at the center of the CFG outer face of the V&#x003B2; and other V-type Ig-like domains. This hydrophobic patch is shielded from solvent exposure in the crystal packing, implying that it is unlikely to be thermodynamically stable if exposed on the thymocyte surface. Accordingly, we propose a dimeric pre-TCR model distinct from those suggested previously by others and discuss its functional and structural implications.</p>
</abstract>
<kwd-group>
<kwd>T cell receptor</kwd>
<kwd>beta chain</kwd>
<kwd>crystal structure</kwd>
<kwd>pre-TCR</kwd>
</kwd-group>
<counts>
<fig-count count="8"/>
<table-count count="1"/>
<equation-count count="0"/>
<ref-count count="52"/>
<page-count count="9"/>
<word-count count="7818"/>
</counts>
</article-meta>
</front>
<body>
<sec sec-type="introduction">
<title>Introduction</title>
<p>The &#x003B1;&#x003B2; T cell receptor (TCR) is a multimeric complex consisting of the antigen-binding &#x003B1;&#x003B2; clonotypic heterodimer and six invariant CD3 subunit dimers (Sun et al., <xref ref-type="bibr" rid="B39">2001</xref> and references therein). Specific interaction between the TCR&#x003B1;&#x003B2; heterodimer and an antigenic peptide bound to an MHC molecule (pMHC) triggers downstream signaling, resulting in T cell activation (Rudolph et al., <xref ref-type="bibr" rid="B34">2006</xref>; Acuto et al., <xref ref-type="bibr" rid="B1">2008</xref>; Smith-Garvin et al., <xref ref-type="bibr" rid="B37">2009</xref>). TCR signaling is also critical for thymocyte differentiation (Ghendler et al., <xref ref-type="bibr" rid="B19">1998</xref>; Mariathasan et al., <xref ref-type="bibr" rid="B32">1999</xref>; Love et al., <xref ref-type="bibr" rid="B31">2000</xref>; Haks et al., <xref ref-type="bibr" rid="B23">2002</xref>). In early thymic development, the first major checkpoint is referred to as &#x003B2;-selection. During this process TCR&#x003B2; chain gene rearrangement occurs in the absence of TCR&#x003B1; chain gene rearrangements (Von Boehmer et al., <xref ref-type="bibr" rid="B43">2003</xref>). The expressed TCR&#x003B2; chain associates with the invariant pre-T&#x003B1; (pT&#x003B1;), which leads to the formation of pre-TCR on the cell surface. Signaling through the pre-TCR terminates TCR&#x003B2; locus rearrangement, rescues cells from apoptosis and induces massive proliferation. This process eventually enables CD4<sup>&#x02212;</sup>CD8<sup>&#x02212;</sup> double-negative (DN) cells to differentiate into CD4<sup>&#x0002B;</sup>CD8<sup>&#x0002B;</sup> double-positive (DP) cells, facilitating TCR&#x003B1; gene rearrangement and thus generating a large &#x003B1;&#x003B2;TCR repertoire (Von Boehmer et al., <xref ref-type="bibr" rid="B43">2003</xref>). DP thymocytes undergo positive selection and negative selection following self&#x02013;MHC interaction with their &#x003B1;&#x003B2;TCR. In the former case, DP cells mature into single positive (SP) thymocytes and may egress into the periphery (Starr et al., <xref ref-type="bibr" rid="B38">2003</xref>; Juang et al., <xref ref-type="bibr" rid="B25">2010</xref>). In the latter case, cell death occurs and those apoptotic thymocytes are purged from the T lineage repertoire (Gallegos and Bevan, <xref ref-type="bibr" rid="B18">2006</xref>; Ashton-Rickardt, <xref ref-type="bibr" rid="B4">2007</xref>; Griesemer et al., <xref ref-type="bibr" rid="B22">2010</xref>).</p>
<p>The development of &#x003B1;&#x003B2; lineage thymocytes and the antigen recognition of mature T cells are critically dependent on the TCR&#x003B2; chain. Certain germline-encoded amino acids within the TCR V&#x003B2; domain promote &#x0201C;generic&#x0201D; recognition of MHC molecules during the thymic selection process (Scott-Browne et al., <xref ref-type="bibr" rid="B35">2009</xref>). The germline-encoded TCR V&#x003B2;&#x02013;MHC interactions have evolved to pre-determine, or at least strongly influence, the conserved diagonal TCR&#x02013;MHC binding mode (Feng et al., <xref ref-type="bibr" rid="B15">2007</xref>). The V&#x003B2; domain&#x02019;s unique contribution has also been shown in providing a structural basis for immunodominance (Ishizuka et al., <xref ref-type="bibr" rid="B24">2008</xref>; Wang et al., <xref ref-type="bibr" rid="B46">2008</xref>). Immunodominant CTL responses to EBV infection incorporate a particular rearranged &#x003B2; chain generated during thymic development, favoring the survival, and expansion of T cells bearing it (Argaet et al., <xref ref-type="bibr" rid="B3">1994</xref>; Gras et al., <xref ref-type="bibr" rid="B21">2009</xref>). Another example involves the conservation of one V&#x003B2; domain in the context of highly variable V&#x003B1; usage, as found in B6 mice responding to the immunodominant D<sup>b</sup>-restricted NP<sub>366&#x02013;374</sub> influenza A peptide following PR8 viral infection (Zhong and Reinherz, <xref ref-type="bibr" rid="B52">2004</xref>; Zhong et al., <xref ref-type="bibr" rid="B51">2007</xref>). The above observations raise the interesting possibility as to whether the V&#x003B2; recognition itself during &#x003B2;-selection can mediate a physiologic binding event in a manner analogous to certain VH domains in antibody molecules (Ward et al., <xref ref-type="bibr" rid="B48">1989</xref>).</p>
<p>The alternative view regarding &#x003B2;-selection is that it is an autonomous signaling process driven by the oligomerization of pre-TCR&#x02019;s extracellular domain (Yamasaki et al., <xref ref-type="bibr" rid="B49">2006</xref>; Yamasaki and Saito, <xref ref-type="bibr" rid="B50">2007</xref>). Very recently, Pang et al., <xref ref-type="bibr" rid="B33">2010</xref> determined the crystal structure of a pre-TCR and, following crystal packing analysis, proposed a model for autonomous dimerization of pre-TCR. In this model, a pT&#x003B1; domain&#x02019;s ABED face contacts the &#x003B2; chain&#x02019;s C&#x003B2; domain to form a pT&#x003B1;/C&#x003B2; module, similar to the C&#x003B1;/C&#x003B2; module seen in the &#x003B1;&#x003B2;TCR heterodimer. In addition, the other face of the pT&#x003B1; domain (the CFG face) interacts with a V&#x003B2; domain from the neighboring molecule in the crystal lattice, resulting in a dimeric pre-TCR. In this way, the &#x0201C;head-to-tail&#x0201D; pre-TCR dimer referred to by the authors, should it adopt this topology <italic>in vivo</italic>, would sit almost parallel to the cellular membrane surface such that the V&#x003B2; domain becomes virtually unable to access any potential ligand (Pang et al., <xref ref-type="bibr" rid="B33">2010</xref>). This contrasts with the upright model of the mature &#x003B1;&#x003B2;TCR complex, which is arrayed on the T cell surface with six CDR loops pointing upward to facilitate immune recognition (Sun et al., <xref ref-type="bibr" rid="B40">2004</xref>).</p>
<p>We report here crystal structures of two &#x003B2; subunit ectodomains, N15&#x003B2; (V&#x003B2;5.2D&#x003B2;2J&#x003B2;2.6C&#x003B2;2), and N30&#x003B2; (V&#x003B2;13D&#x003B2;1J&#x003B2;1.1C&#x003B2;2), derived from N15 and N30 &#x003B1;&#x003B2;TCRs (Chang et al., <xref ref-type="bibr" rid="B8">1997</xref>; Goyarts et al., <xref ref-type="bibr" rid="B20">1998</xref>). We have compared these structures with the previously published structure of a TCR &#x003B2; subunit (V&#x003B2;8.2J&#x003B2;2.1C&#x003B2;1; Bentley et al., <xref ref-type="bibr" rid="B5">1995</xref>) and several others in the protein data bank. In the structures surveyed, a few conserved residues were identified on the CFG face of V&#x003B2; Ig-like domain. In the biological heterodimeric &#x003B1;&#x003B2;TCR these residues are located at the V&#x003B1;/V&#x003B2; interface. In the V&#x003B2; structures studied, the same residues are shielded from exposure by crystal packing in one of several possible ways. Based on these observations, we have proposed an alternative pre-TCR dimer model that is more similar to the heterodimeric &#x003B1;&#x003B2;TCR, and discussed its biological significance.</p>
</sec>
<sec sec-type="materials|methods">
<title>Materials and Methods</title>
<sec>
<title>Cloning, expression and purification of N15&#x003B2; and N30&#x003B2;</title>
<p>Gene encoding the extracellular domain of N15&#x003B2; and N30&#x003B2; subunits was cloned into the expression vector pET-11d (Novagen). The DNA sequence of N15&#x003B2; and N30&#x003B2; constructs were terminated immediately after the cysteine of the respective TCR&#x003B2; subunit involved in interchain disulfide formation with the cysteine itself mutated to serine. The recombinant plasmid was then transformed into <italic>Escherichia coli</italic> strain BL21 (DE3) followed by the induction of N15&#x003B2; and N30&#x003B2; expression using 1&#x02009;mM isopropyl-&#x003B2;-D-thiogalactopyranoside. Inclusion bodies were isolated and solubilized in 6&#x02009;M guanidine&#x02013;HCl. The refolding of protein was achieved by further dilution of the inclusion bodies in a cold buffer containing 100&#x02009;mM Tris&#x02013;HCl (pH 8.0), 5.4&#x02009;M guanidine&#x02013;HCl, 1&#x02009;M L-arginine&#x02013;HCl, 1&#x02009;mM reduced glutathione, and 0.1&#x02009;mM oxidized glutathione, followed by dialysis against 20&#x02009;mM Tris&#x02013;HCl (pH 8.0), 10&#x02009;mM NaCl at 4<sup>&#x000B0;</sup>C for 12&#x02009;h. Insoluble particles were removed by centrifugation at high speed. The refolding mixture was concentrated prior to sequential purification of refolded proteins on a Sephacryl S-300 column and a Superdex 75 column (GE Healthcare).</p>
</sec>
<sec>
<title>Crystallization and structure determination</title>
<p>Crystals were grown at room temperature by the hanging-drop vapor diffusion method. Equal volumes of protein solution (15&#x02009;mg/ml in 20&#x02009;mM HEPES pH 7.5, 100&#x02009;mM NaCl) and reservoir solution (100&#x02009;mM HEPES pH 7.0, 20&#x00025; PEG3350 for N15&#x003B2;, or 100&#x02009;mM Tris&#x02013;HCl pH 8.5, 20&#x00025; PEG4000 for N30&#x003B2;) were mixed and crystals appeared in 1&#x02013;2&#x02009;days. 15&#x00025; glycerol was added in reservoir buffer as a cryoprotectant solution to soak crystals prior to freezing. Diffraction data were collected at beamline 24-ID-E at the Argonne National Laboratories.</p>
<p>The structures were determined by molecular replacement method. TCR&#x003B2; structures taken from heterodimeric &#x003B1;&#x003B2;TCR models with PDB accession code 1NFD and 1LP9 were used as the templates for searching N15&#x003B2; and N30&#x003B2; structures, respectively. The solution of N30&#x003B2; structure could only be obtained when V&#x003B2; and C&#x003B2; domains were used as the templates separately. The models were refined using refmac5 (Vagin et al., <xref ref-type="bibr" rid="B41">2004</xref>) or phenix (Adams et al., <xref ref-type="bibr" rid="B2">2010</xref>), viewed and adjusted by Coot (Emsley and Cowtan, <xref ref-type="bibr" rid="B14">2004</xref>), and validated by MolProbity (Davis et al., <xref ref-type="bibr" rid="B12">2007</xref>). The data collection and refinement statistics are listed in Table <xref ref-type="table" rid="T1">1</xref>. The coordinates of the N15&#x003B2; and N30&#x003B2; structures have been deposited in the Protein Data Bank with the code 3Q5Y and 3Q5T, respectively.</p>
<table-wrap position="float" id="T1">
<label>Table 1</label>
<caption><p><bold>Data collection and refinement statistics</bold>.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center"/>
<th align="center">N15&#x003B2;</th>
<th align="center">N30&#x003B2;</th>
</tr>
</thead>
<tbody>
<tr style="background-color:gray;">
<td align="left" colspan="3"><bold>DATA COLLECTION</bold></td>
</tr>
<tr>
<td align="left">Space group</td>
<td align="left">P212121</td>
<td align="left">C2221</td>
</tr>
<tr>
<td align="left">Unit cell parameters (&#x000C5;, &#x000B0;)</td>
<td align="left"><italic>a</italic>&#x02009;&#x0003D;&#x02009;78.2, <italic>b</italic>&#x02009;&#x0003D;&#x02009;129.6, <italic>c</italic>&#x02009;&#x0003D;&#x02009;129.7, &#x003B1;&#x02009;&#x0003D;&#x02009;&#x003B2;&#x02009;&#x0003D;&#x02009;&#x003B3;&#x02009;&#x0003D;&#x02009;90</td>
<td align="left"><italic>a</italic>&#x02009;&#x0003D;&#x02009;53.3, <italic>b</italic>&#x02009;&#x0003D;&#x02009;69.8, <italic>c</italic>&#x02009;&#x0003D;&#x02009;129.4, &#x003B1;&#x02009;&#x0003D;&#x02009;&#x003B2;&#x02009;&#x0003D;&#x02009;&#x003B3;&#x02009;&#x0003D;&#x02009;90</td>
</tr>
<tr>
<td align="left">Resolution</td>
<td align="left">20&#x02013;1.9 (1.93&#x02013;1.90)</td>
<td align="left">20&#x02013;2.0 (2.05&#x02013;2.0)</td>
</tr>
<tr>
<td align="left">Completeness (&#x00025;)</td>
<td align="left">99.4 (97.0)</td>
<td align="left">99.9 (100)</td>
</tr>
<tr>
<td align="left"><italic>R</italic><sub>sym</sub><xref ref-type="table-fn" rid="tfn1"><sup>a</sup></xref> (&#x00025;)</td>
<td align="left">10.3 (60.5)</td>
<td align="left">6.0 (61.6)</td>
</tr>
<tr>
<td align="left"><italic>I</italic>/&#x003C3; (I)</td>
<td align="left">20.6 (2.6)</td>
<td align="left">19.2 (2.5)</td>
</tr>
<tr>
<td align="left">Redundancy</td>
<td align="left">8.3 (3.8)</td>
<td align="left">6.5 (6.5)</td>
</tr>
<tr>
<td align="left">Unique reflections</td>
<td align="left">97,771</td>
<td align="left">16,199</td>
</tr>
<tr style="background-color:gray;">
<td align="left" colspan="3"><bold>REFINEMENT</bold></td>
</tr>
<tr>
<td align="left"><italic>R</italic><sub>work</sub><xref ref-type="table-fn" rid="tfn2"><sup>b</sup></xref> (&#x00025;)</td>
<td align="left">17.8</td>
<td align="left">23.5</td>
</tr>
<tr>
<td align="left"><italic>R</italic><sub>free</sub><xref ref-type="table-fn" rid="tfn3"><sup>c</sup></xref> (&#x00025;)</td>
<td align="left">21.8</td>
<td align="left">28.9</td>
</tr>
<tr>
<td align="left">Rmsd bonds (&#x000C5;)</td>
<td align="left">0.008</td>
<td align="left">0.007</td>
</tr>
<tr>
<td align="left">Rmsd angles (&#x000B0;)</td>
<td align="left">1.122</td>
<td align="left">1.097</td>
</tr>
<tr>
<td align="left">Ramachandran (&#x00025;; favored, allowed, outlier)</td>
<td align="left">96.9, 3.1, 0</td>
<td align="left">92.8, 5.9, 1.3</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>Values in parentheses refer to the highest resolution shell</italic>.</p>
<fn id="tfn1"><p><italic><sup>a</sup><italic>R</italic><sub>sym</sub>&#x02009;&#x0003D;&#x02009;&#x02211;&#x02502;<italic>I</italic>&#x02009;&#x02212;&#x02009;&#x0003C;<italic>I</italic>&#x0003E;&#x02502;/&#x02211;<italic>I</italic></italic>.</p></fn>
<fn id="tfn2"><p><italic><sup>b</sup><italic>R</italic><sub>cryst</sub>&#x02009;&#x0003D;&#x02009;&#x02211;&#x02551;<italic>F</italic><sub>o</sub>&#x02502;&#x02009;&#x02212;&#x02009;&#x02502;<italic>F</italic><sub>c</sub>&#x02502;/&#x02211;&#x02502;<italic>F</italic><sub>o</sub></italic>&#x02502;.</p></fn>
<fn id="tfn3"><p><sup>c</sup><italic>R<sub>free</sub> is the R-factor for a selected subset (5&#x00025;) of the reflections which are not included in prior refinement calculations</italic>.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
</sec>
<sec>
<title>Results</title>
<sec>
<title>Structures of N15&#x003B2; and N30&#x003B2;</title>
<p>The 240-residue N15 and N30 &#x003B2; subunits were expressed in <italic>E. coli</italic> and crystallized readily. Their structures were determined using molecular replacement, with R-factor of 0.178 and <italic>R</italic><sub>free</sub> of 0.218 for N15&#x003B2; to 1.9&#x02009;&#x000C5;, and 0.235 and 0.289 for N30&#x003B2; to 2.0&#x02009;&#x000C5;, respectively (see Table <xref ref-type="table" rid="T1">1</xref> for statistics). As shown in Figure <xref ref-type="fig" rid="F1">1</xref>, each of the models encompasses two Ig-like domains, V&#x003B2; and C&#x003B2;.</p>
<p>The superposition of the isolated N15&#x003B2; protein onto the &#x003B2; subunit of our previously published N15 &#x003B1;&#x003B2;TCR heterodimer (PDB code 1NFD) provides one of the first examples demonstrating that there are no significant conformational changes upon TCR&#x003B2; pairing with TCR&#x003B1; to form an intact &#x003B1;&#x003B2;TCR. If the superposition is based on the V&#x003B2; domain, then the two corresponding C&#x003B2; domains only have a few degree rigid-body rotation relative to each other (Figure <xref ref-type="fig" rid="F2">2</xref> and <italic>vide infra</italic>). We previously reported that the quaternary arrangement of V&#x003B2;&#x02013;C&#x003B2; varies among different TCR molecules (Wang et al., <xref ref-type="bibr" rid="B45">1998</xref>). Our current results suggest that for each individual TCR&#x003B2;, the quaternary arrangement of V&#x003B2;&#x02013;C&#x003B2; domains might be intrinsic, determining at least in part to which &#x003B1; subunit it can pair. A general survey indicates that upon TCR ligation to pMHC, the major conformational changes are limited to the CDR loops of each subunit (Rudolph et al., <xref ref-type="bibr" rid="B34">2006</xref>). The rigidity of the framework module of TCR molecules seems to be essential for signaling following pMHC bindings (Kim et al., <xref ref-type="bibr" rid="B27">2009</xref>).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p><bold>Structures of N30 TCR&#x003B2; and N15 TCR&#x003B2; subunits</bold>. The two Ig-like domains, V&#x003B2; and C&#x003B2;, are at the top and bottom, respectively.</p></caption>
<graphic xlink:href="fimmu-02-00005-g001.tif"/>
</fig>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption><p><bold>Superposition of the N15&#x003B2; homodimer onto the N15&#x003B1;&#x003B2; TCR heterodimer</bold>. The overlay was based on the V&#x003B2; domain in red from the homodimer and in green from the heterodimer (top left in the figure). The pink subunit is the pairing N15&#x003B2; subunit in the homodimer, whereas the lime subunit is the pairing N15&#x003B1; subunit in the heterodimer. Note that in &#x003B1;&#x003B2;TCR heterodimer, C&#x003B2; and C&#x003B1; pair to form a C module, whereas in the N15&#x003B2; homodimer, the two C&#x003B2; domains do not contact each other, but instead point in opposite directions.</p></caption>
<graphic xlink:href="fimmu-02-00005-g002.tif"/>
</fig>
</sec>
<sec>
<title>The V&#x003B2;/V&#x003B2; homodimer of N15&#x003B2; is similar to V&#x003B1;/V&#x003B2; heterodimer of N15 &#x003B1;&#x003B2;TCR</title>
<p>A particularly intriguing feature of the N15&#x003B2; crystal structure is that two N15&#x003B2; subunits pack to form a V&#x003B2;/V&#x003B2; homodimer in a fashion very similar to that of the V&#x003B1;/V&#x003B2; module in the &#x003B1;&#x003B2;TCR heterodimer. In each asymmetric unit of the N15&#x003B2; crystal there are four N15&#x003B2; molecules that pair to form two homodimers, using their outer faces of CFG &#x003B2; sheet for contacts. Figure <xref ref-type="fig" rid="F2">2</xref> shows the overlay of a crystallographic homodimer of N15&#x003B2; onto the N15 &#x003B1;&#x003B2;TCR heterodimer. The superposition is based on the V&#x003B2; domains (in red and green color, respectively, for N15&#x003B2; and N15 &#x003B1;&#x003B2;TCR structures). In this figure, the small movement of the C&#x003B2; domain in the TCR&#x003B2; relative to the &#x003B1;&#x003B2;TCR can be clearly seen. The respective pairing domains, V&#x003B2; (in pink color, from the homodimer) and V&#x003B1; (in lime color, from the heterodimer) are similarly oriented, differing by only 11<sup>&#x000B0;</sup> from each other (Figure <xref ref-type="fig" rid="F2">2</xref>). In both the &#x003B2;&#x003B2; homodimer and &#x003B1;&#x003B2; heterodimer, the two pairing V-type Ig-like domains combine in an aligned arrangement with their corresponding &#x003B2; strands&#x02019; directions at an acute angle to one another.</p>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption><p><bold>A conserved concave hydrophobic patch in the CFG face of the TCR V&#x003B2; domain</bold>. <bold>(A)</bold> In the N15&#x003B2; homodimer, the conserved hydrophobic residues form an interface. The two Gln37 residues from two V&#x003B2; protomers within the homodimer form two hydrogen-bonds in the interface, which orient the two domains in a packing pattern with constituent &#x003B2; strands roughly aligned. Note that the numbering of the residues follow the structure of N15&#x003B1;&#x003B2; TCR (PDB 1NFD); <bold>(B)</bold> In the N15&#x003B1;&#x003B2; TCR heterodimer, the conserved hydrophobic residues of the V&#x003B2; domain are in contacts with similar residues of V&#x003B1; domain to form an interface. There are also two hydrogen-bonds between two invariant Gln37 residues, playing the identical role. Furthermore, V&#x003B1;&#x02019;s Tyr35 forms a hydrogen bond with the main chain carbonyl group on the V&#x003B2; domain, providing an additional force favoring the correct domain/domain orientation register; <bold>(C)</bold> Selected sequence alignment of several TCR subunits. The yellow shade marks conserved residues that are key for folding, whereas the green shade marks the conserved residues that constitute the hydrophobic interface and the invariant Gln/Gln pairing; <bold>(D)</bold> Surface representations of the V&#x003B2; domain&#x02019;s CFG and ABED faces. The red color represents negatively charged, blue color positively charged, and gray color hydrophobic residues. The concave hydrophobic patch is obvious at the center of CFG face.</p></caption>
<graphic xlink:href="fimmu-02-00005-g003.tif"/>
</fig>
<p>Figure <xref ref-type="fig" rid="F3">3</xref> depicts the key interface residues in the N15 V&#x003B2;/V&#x003B2; structure (Figure <xref ref-type="fig" rid="F3">3</xref>A) and those in the V&#x003B1;/V&#x003B2; interface in the N15 &#x003B1;&#x003B2;TCR structure (Figure <xref ref-type="fig" rid="F3">3</xref>B). Both interfaces involve Tyr35, Gln37, Phe91, and Phe108, as well as Leu43 in V&#x003B2; or Pro43 in V&#x003B1;. The three aromatic residues along with Leu43 (or Pro43) form a hydrophobic center at the CFG interface. These residues are conserved in the variable domains of the TCR (Chothia et al., <xref ref-type="bibr" rid="B10">1988</xref>; as shown for selected TCR variable domains in Figure <xref ref-type="fig" rid="F3">3</xref>C) and antibody molecules (Chothia et al., <xref ref-type="bibr" rid="B11">1998</xref>). Figure <xref ref-type="fig" rid="F3">3</xref>D is an electrostatic surface representation of V&#x003B2; domain&#x02019;s CFG face and the opposite ABED face for comparison. Whereas the exposed ABED face is fully covered by positive and negative charges, by contrast, a concave hydrophobic patch at the center of CFG outer face is readily discernible. Any exposed hydrophobic patch this size may not be stable, necessitating shielding from the solvent environment. On the other hand, the sole hydrophilic residue on the CFG face within this patch, the Gln37, plays a distinct role. In both the N15&#x003B2; and N15 &#x003B1;&#x003B2;TCR structures, this Gln37 on the C strand forms two hydrogen-bonds with its dimeric counterpart near the bottom of the interface between two V-domains (Figures <xref ref-type="fig" rid="F3">3</xref>A,B). This Gln has been reported to be invariant in variable domains of TCRs and antibodies (Chothia et al., <xref ref-type="bibr" rid="B10">1988</xref>, <xref ref-type="bibr" rid="B11">1998</xref>). Presumably the hydrogen-bonds offered by Gln37 provide a correct register for the two variable domains to dock. In Figure <xref ref-type="fig" rid="F3">3</xref>B the V&#x003B1; domain&#x02019;s Tyr35 forms an additional direct hydrogen bond with the main chain carbonyl oxygen of Gln106 of the V&#x003B2; domain near the top of the V&#x003B1;/V&#x003B2; interface. This is also a conserved feature of the &#x003B1;&#x003B2;TCR V&#x003B1;/V&#x003B2; interface in general. In the V&#x003B2;/V&#x003B2; interface of the N15&#x003B2; structure, the Tyr35&#x02019;s side chain appears slightly far from Gln106&#x02019;s carbonyl oxygen (around 4.5&#x02009;&#x000C5;) for a hydrogen bond (Figure <xref ref-type="fig" rid="F3">3</xref>A). It is interesting to note that there is a HEPES [4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid] solvent molecule intercalated into the V&#x003B2;/V&#x003B2; interface adjacent to Tyr35 for each of two N15&#x003B2; homodimers in the crystal structure, which prevents Tyr35 from forming a hydrogen bond to carbonyl oxygen of Gln106 (Figure <xref ref-type="fig" rid="FA1">A1</xref> in Appendix). Notwithstanding, the N15&#x003B2; V&#x003B2;/V&#x003B2; homodimer is very similar overall to the N15 &#x003B1;&#x003B2;TCR V&#x003B1;/V&#x003B2; heterodimer.</p>
<p>There are structural differences, however, between the V&#x003B2;/V&#x003B2; homodimers and V&#x003B1;/V&#x003B2; heterodimers. For example, using the buried area option in the CNS program package (Brunger et al., <xref ref-type="bibr" rid="B6">1998</xref>), we calculate that the surface buried area for the N15 V&#x003B2;/V&#x003B2; homodimer is 1,291&#x02009;&#x000C5;<sup>2</sup>, significantly smaller than 1,523&#x02009;&#x000C5;<sup>2</sup> for the N15 V&#x003B1;/V&#x003B2; heterodimer. Moreover, the complementary fitness index, or Sc value (Lawrence and Colman, <xref ref-type="bibr" rid="B29">1993</xref>) of the V&#x003B2;/V&#x003B2; homodimer and V&#x003B1;/V&#x003B2; heterodimer is 0.469 and 0.545, respectively, indicating a poorer fit at the homodimer interface relative to that of the heterodimer. This differential result reflects the self-association affinity difference between these dimers. Notably, the asymmetric TCR molecule has a much sharper bending angle between V&#x003B2; and C&#x003B2; domains compared to that between V&#x003B1; and C&#x003B1; domains (Wang et al., <xref ref-type="bibr" rid="B45">1998</xref>). Thus, when two N15&#x003B2; molecules&#x02019; V&#x003B2; domains form a V&#x003B2;/V&#x003B2; homodimer, the two corresponding C&#x003B2; domains do not meet to form a C module like that of C&#x003B1;/C&#x003B2; in the &#x003B1;&#x003B2;TCR molecule, as evident in Figure <xref ref-type="fig" rid="F2">2</xref>. These data suggest that it is possible to form a homodimer between two TCR &#x003B2; subunits through their V&#x003B2; domains, but that the homodimer so formed is substantially less stable than the &#x003B1;&#x003B2;TCR heterodimer.</p>
<p>The observed V&#x003B2;/V&#x003B2; homodimer in the crystal lattice may well be of biological significance. For instance, using RAG-2<sup>&#x02212;/&#x02212;</sup> deficient mice for functional studies, it was found that the introduction of a TCR&#x003B2; transgene, but not a TCR&#x003B1; transgene restores T cell development, allowing thymocytes to transit from the DN to the DP stage. These DP cells were observed to express monomeric TCR&#x003B2; chains in association with CD3&#x00393;&#x003B4;&#x003B5; but not &#x003B6;&#x003B6;, as well as small amounts of &#x003B2; homodimers (Shinkai et al., <xref ref-type="bibr" rid="B36">1993</xref>). We shall come back to these points later.</p>
</sec>
<sec>
<title>The shielding of the exposed hydrophobic CFG face of the V&#x003B2; domain is a common feature in other crystal structures that contain TCR&#x003B2;</title>
<p>There is only one molecule in the asymmetric unit of the N30&#x003B2; crystals. The symmetry-related molecules pack very differently from those of the N15&#x003B2; crystal, with one molecule&#x02019;s C&#x003B2; domain packing onto the other molecule&#x02019;s V&#x003B2; domain as shown in Figure <xref ref-type="fig" rid="F4">4</xref>A. Despite the apparent difference, the hydrophobic surface of the N30&#x003B2; V&#x003B2; domain (the CFG face) is also shielded from solvent exposure by the ABED face of a neighboring molecule&#x02019;s C&#x003B2; domain. It is not surprising to observe the involvement of the C&#x003B2; domain&#x02019;s ABED face; this face is normally engaged in the contacts with the C&#x003B1; domain&#x02019;s ABED face to form the C module in &#x003B1;&#x003B2;TCR molecules. One prominent feature in the N30&#x003B2; structure is that the aromatic ring of Phe128 of this C&#x003B2; domain pokes into the concave hydrophobic patch of the V&#x003B2; domain from the symmetry-related molecule for interaction (Figure <xref ref-type="fig" rid="F4">4</xref>A). That may explain the higher Sc value (0.540) for this interface as opposed to 0.469 in the N15&#x003B2; V&#x003B2;/V&#x003B2; interface, and why this peculiar packing is favored.</p>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption><p><bold>Packing patterns observed in other structures containing TCR &#x003B2; chain</bold>. <bold>(A)</bold> The CFG face of the N30 TCR&#x003B2; is shielded by the neighboring molecule&#x02019;s ABED face. Note that F128 of the C&#x003B2; subunit pokes into the concave hydrophobic patch of V&#x003B2;&#x02019;s CFG face; <bold>(B)</bold> The orthogonal packing between two V&#x003B2; domains&#x02019; CFG faces frequently observed in crystal structures containing TCR&#x003B2;. In the figure is the first solved TCR&#x003B2; structure (PDB code 1BEC).</p></caption>
<graphic xlink:href="fimmu-02-00005-g004.tif"/>
</fig>
<p>The observations on N15&#x003B2; and N30&#x003B2; structures led us to carry out an extensive survey in the protein data bank to investigate whether, in general, a TCR variable domain&#x02019;s hydrophobic CFG face shown in Figure <xref ref-type="fig" rid="F3">3</xref>D is shielded from solvent exposure by crystal packing in various individual (i.e., non-heterodimeric) TCR subunit structures. In retrospect, the first glimpse at a TCR was derived from the structure of a &#x003B2; subunit (V&#x003B2;8.2J&#x003B2;2.1C&#x003B2;1, with PDB code of 1BEC; Bentley et al., <xref ref-type="bibr" rid="B5">1995</xref>). Over the last 15&#x02009;years, dozens of TCR single-subunit structures have been deposited in the data bank, including TCR&#x003B2;, also TCR&#x003B1;, and even TCR&#x003B4;. Many of these TCR &#x003B2; subunit structures are in complex with ligands such as superantigens. In the structure of 1BEC, the hydrophobic surface of the V&#x003B2; domain&#x02019;s CFG face was indeed shielded by crystal packing (Figure <xref ref-type="fig" rid="F4">4</xref>B). However, in that structure the two contacting V&#x003B2; domains&#x02019; &#x003B2; strands are not aligned in the same manner as seen in the N15&#x003B2; and N15 &#x003B1;&#x003B2;TCR structures. Rather, in the 1BEC structure, molecules are in an orthogonal packing pattern, similar to the CD2/CD58 adhesion molecule pair (Wang et al., <xref ref-type="bibr" rid="B47">1999</xref>). Interestingly, the majority of those TCR&#x003B2; structures, be they in isolation or in complex with ligands, have an orthogonal packing in crystals to shield their hydrophobic CFG faces from solvent exposure.</p>
<p>It is particularly noteworthy that an aligned homodimer was observed in the first TCR V&#x003B1; domain structure from the &#x003B1;&#x003B2;TCR1934.4 specific for the N-terminal nonapeptide of myelin basic protein bound to the MHC class II molecule I-A<sup>u</sup> (Fields et al., <xref ref-type="bibr" rid="B16">1995</xref>). The same research group later published a mutant 1934.4V&#x003B1;<sub>mut</sub> structure and observed a V&#x003B1;/V&#x003B1; homodimer resembling the V&#x003B1;/V&#x003B2; heterodimer of &#x003B1;&#x003B2;TCR 2C and A6 (Li et al., <xref ref-type="bibr" rid="B30">1997</xref>). Moreover, this protein formed homodimers in solution as well (Fields et al., <xref ref-type="bibr" rid="B17">1994</xref>).</p>
</sec>
<sec>
<title>Stable, single-subunit molecules do not have an exposed hydrophobic patch</title>
<p>We further sought to carry out comparative investigation of the two co-receptors: CD4 and CD8. CD8 exists either as a CD8&#x003B1;&#x003B1; homodimer or a CD8&#x003B1;&#x003B2; heterodimer on the T cell surface, whereas CD4 is a monomeric molecule. The N-terminal domains of these two co-receptors are both V-type Ig-like domain. Figures <xref ref-type="fig" rid="F5">5</xref>A,B are electrostatic surface representations of the N-terminal V-domain CFG face of CD8&#x003B2; and CD4, respectively. The contrast is obvious. Whereas the single-subunit CD4 does not have a hydrophobic patch at the center of the CFG face of its N-terminal domain, CD8&#x003B2; does, analogous to that observed in the TCR&#x003B2; subunit. This CD8 feature is linked to the fact that CD8&#x003B2; uses its single Ig-like domain to pair with CD8&#x003B1; in order to form a functional heterodimer. This further provides evidence that any membrane distal V-type Ig-like domain in a transmembrane protein is likely to form a dimer to shield its hydrophobic patch, if it exists, at the center of the CFG face from exposure. Moreover, in the case of the CD8&#x003B1;&#x003B1; homodimer the conserved Gln41 plays an identical role as Gln37 for the TCR to form two hydrogen-bonds creating the correct domain&#x02013;domain interface register (PDB code 1BQH; Kern et al., <xref ref-type="bibr" rid="B26">1998</xref>).</p>
<fig id="F5" position="float">
<label>Figure 5</label>
<caption><p><bold>Other immune molecules&#x02019; CFG face</bold>. <bold>(A)</bold> CD8&#x003B2; subunit. A hydrophobic &#x0201C;well&#x0201D; is obvious at the center; <bold>(B)</bold> CD4 N-terminal V-type domain. This single-subunit TCR co-receptor does not have a hydrophobic CFG face at its N-terminal V-type domain; <bold>(C)</bold> Camelid antibody&#x02019;s V-type domain. This unique antibody does not have a light chain to pair with the heavy chain. Although there is a hydrophobic &#x0201C;well&#x0201D; at its CFG face, this area is shielded from exposure by an extraordinarily long FG loop (in red color).</p></caption>
<graphic xlink:href="fimmu-02-00005-g005.tif"/>
</fig>
<p>It is interesting that camelids possess a functional class of antibodies devoid of light chain (Desmyter et al., <xref ref-type="bibr" rid="B13">1996</xref>). Figure <xref ref-type="fig" rid="F5">5</xref>C demonstrates that its V<sub>H</sub> domain does have the conserved aromatic residues Phe37, Tyr95, and Tyr120 (equivalent positions Tyr35, Phe91, and Phe108 in TCR&#x003B2;, respectively) at the otherwise-exposed hydrophobic patch. However, this camelid molecule has an extraordinarily long FG loop curving into an extra helix that shields off this hydrophobic patch. This structural feature explains why this single heavy-chain antibody is functionally stable in the absence of a V-domain dimeric structure.</p>
<fig id="F6" position="float">
<label>Figure 6</label>
<caption><p><bold>The dimeric pre-TCR models</bold>. <bold>(A)</bold> The upward projecting pre-TCR model was built based on the N15&#x003B2; homodimer as a starting point. This model has a topology similar to that of a mature &#x003B1;&#x003B2;TCR heterodimer with CDR loops pointing up, and thereby available for potential ligand-binding. It also may accommodate CD3 subunits in a somewhat similar manner as &#x003B1;&#x003B2;TCR. Note that the CD3 heterodimer ectodomains can be accommodated adjacent to the C&#x003B2; FG loops, one of which is highlighted in blue (left and right panels differ by about 150<sup>&#x000B0;</sup> rotation around the vertical axis). Pre-TCR residues Asp22 and Lys24 (blue side-chains) were suggested to facilitate pre-TCR oligomerization (Yamasaki et al., <xref ref-type="bibr" rid="B49">2006</xref>). The N-linked glycan attachment sites at N51 and N101 of Pre-T&#x003B1; are shown in blue space-filling models; <bold>(B)</bold> The &#x0201C;head-to-tail&#x0201D; flat pre-TCR dimer proposed by Pang et al., <xref ref-type="bibr" rid="B33">2010</xref>. The two V&#x003B2; domains point in opposite directions, virtually parallel to the membrane, and hence difficult for any potential ligand interaction. While the human Pre-T&#x003B1; has only the single N51 glycan addition site, the position of the second glycosylation site of N101 in mouse (S101 in human) is also indicated, as in Figure <xref ref-type="fig" rid="F6">6</xref>A.</p></caption>
<graphic xlink:href="fimmu-02-00005-g006.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>The above observation has led to the following key conclusion: for structural stability, a TCR V&#x003B2; domain must shield the conserved hydrophobic patch on its CFG face from exposure to solvent. The patterns of shielding can vary, either through V&#x003B1;/V&#x003B2; interaction in the case of the &#x003B1;&#x003B2;TCR heterodimer, V&#x003B2;/V&#x003B2; aligned homodimeric interaction in the N15&#x003B2; structure, V&#x003B2;/V&#x003B2; orthogonal pairing in the structure of 1BEC (Bentley et al., <xref ref-type="bibr" rid="B5">1995</xref>), or anti-parallel V&#x003B2;/V&#x003B2; interaction in the single V&#x003B1; domain structure 2APB (Cho et al., <xref ref-type="bibr" rid="B9">2005</xref>; not shown here) and in the V&#x003B2;/pT&#x003B1; interaction observed in the pre-TCR structure (PDB code: 3OF6; Pang et al., <xref ref-type="bibr" rid="B33">2010</xref>), or V&#x003B2;/C&#x003B2; interaction in the N30&#x003B2; structure, etc. This set of variations may arise in the absence of a receptor&#x02019;s membrane anchoring force where the domain orientation is under less constraint. Moreover, receptors&#x02019; domain/domain interactions are relatively weak (Wang, <xref ref-type="bibr" rid="B44">2002</xref>; van der Merwe and Davis, <xref ref-type="bibr" rid="B42">2003</xref>), and the non-specific hydrophobic interface is therefore not uniquely defined. In this regard, it is worth re-emphasizing the key role that the invariant Gln37 plays, facilitating the orientation register of V&#x003B2; with respect to V&#x003B1; in the &#x003B1;&#x003B2;TCR heterodimer by providing two specific hydrogen-bonds, as shown in Figure <xref ref-type="fig" rid="F3">3</xref>B.</p>
<p>Based on the above analysis, we propose an alternative dimeric pre-TCR model (Figure <xref ref-type="fig" rid="F6">6</xref>A), distinct from the &#x0201C;head-to-tail&#x0201D; &#x0201C;flat&#x0201D; model suggested by Pang et al. (<xref ref-type="bibr" rid="B33">2010</xref>; Figure <xref ref-type="fig" rid="F6">6</xref>B). Our assumption is that the N15&#x003B2; homodimer might represent a physiological dimer existing at an early DN stage of thymocyte development. We superimposed the pre-TCR structure&#x02019;s V&#x003B2; and C&#x003B2; domains (PDB code: 3OF6) onto the N15&#x003B2;&#x02019;s V&#x003B2; and C&#x003B2; domains, separately, for each of the protomers within the N15&#x003B2; homodimer. This then places the pT&#x003B1; domain along with the C&#x003B2; domain as a module without significant steric collision, creating a distinct dimeric pre-TCR as shown in Figure <xref ref-type="fig" rid="F6">6</xref>A. Given that the V&#x003B2;&#x02013;C&#x003B2; bending angle is actually slightly different between the same &#x003B2; subunit in the mature TCR LC13 (PDB code: 1KGC) and in the pre-TCR (PDB code: 3OF6), it is not surprising that this bending angle differs by a few degrees between N15&#x003B2; and LC13&#x003B2; in the pre-TCR.</p>
<p>The dimeric model we have proposed here has several advantageous features. Structurally, as discussed above, the two hydrogen-bonds provided by the invariant Gln37 remain intact (Figure <xref ref-type="fig" rid="F3">3</xref>A). In this sense, the dimeric pre-TCR appears more similar to the mature &#x003B1;&#x003B2;TCR heterodimer. These hydrogen-bonds are absent in the &#x0201C;flat&#x0201D; pre-TCR model proposed by Pang et al., <xref ref-type="bibr" rid="B33">2010</xref>. A more interesting structural feature is that the mouse pT&#x003B1; has two potential glycosylation sites with the NXS sequon, one being Asn51-Gly-Ser at the tip of CC&#x02019; loop and the other Asn101-Arg-Ser at the middle of G strand (Figure <xref ref-type="fig" rid="F6">6</xref>A, left panel). In both cases, the potential glycan adduct would point toward the cellular membrane, perhaps helping the receptor to orient properly on the membrane (Casasnovas et al., <xref ref-type="bibr" rid="B7">1997</xref>). In the human pre-TCR structure (Pang et al., <xref ref-type="bibr" rid="B33">2010</xref>), a clear sugar moiety is seen at Asn51, which is exposed in the Pang&#x02019;s model as shown in Figure <xref ref-type="fig" rid="F6">6</xref>B. Since the human pre-TCR has Ser101 in lieu of murine Asn101, there is no glycosylation site at the middle of the human G strand. Were the mouse pre-TCR to assume the same &#x0201C;head-to-tail&#x0201D; dimeric structure as the human pre-TCR, then the glycan attached to Asn101 (in the place of human Ser101) would seriously collide with the V&#x003B2; domain from its dimeric partner. This can be seen in Figure <xref ref-type="fig" rid="F6">6</xref>B where the Ser101 (in blue sphere) in human pre-TCR is buried between pT&#x003B1; (in red) and V&#x003B2; (in green).</p>
<p>Functionally, our model would allow the CD3 subunits to be incorporated into the pre-TCR dimer complex in a fashion more analogous to that in the mature &#x003B1;&#x003B2;TCR complex (Sun et al., <xref ref-type="bibr" rid="B40">2004</xref>; Kuhns et al., <xref ref-type="bibr" rid="B28">2010</xref>). By contrast, it is difficult to envision where the CD3 subunits can fit in the &#x0201C;flat&#x0201D; dimeric pre-TCR model. Our model also forces the V&#x003B2; domains&#x02019; CDR loops to project up and out from the membrane in a mode similar to that seen in the mature &#x003B1;&#x003B2;TCR. Subsequently, with further differentiation, the TCR&#x003B1; subunit might easily replace pT&#x003B1;. Finally, our postulated orientation of the &#x003B2; chain would not exclude the possibility that during &#x003B2; selection V&#x003B2; recognition in the form of a dimeric pre-TCR could mediate a physiologic binding event with potential ligands in the thymic development process.</p>
<p>In their pre-TCR crystal structure, Pang et al., <xref ref-type="bibr" rid="B33">2010</xref> actually observed two potential pre-TCR dimers generated by crystal packing. In addition to the flat &#x0201C;head-to-tail&#x0201D; dimer described above, a side-by-side dimer was also discussed and presented in their Figure <xref ref-type="fig" rid="FA2">A2</xref> in Appendix. This dimer is mediated by C&#x003B2;/C&#x003B2; interaction and appears to stand on the membrane in a vertical orientation. However, this dimeric model was not regarded by the authors as favorable because it was presumed to sterically block CD3 interaction. By comparison, the dimeric pre-TCR model we have proposed, being more homologous to the mature &#x003B1;&#x003B2;TCR heterodimer, can permit CD3 complex formation as discussed above. This is readily seen from Figure <xref ref-type="fig" rid="F6">6</xref>A right panel, in which the space beneath and/or adjacent to the protruding FG loop of C&#x003B2; could accommodate juxtaposition of the CD3 subunits (Sun et al., <xref ref-type="bibr" rid="B40">2004</xref>; Kuhns et al., <xref ref-type="bibr" rid="B28">2010</xref>). Moreover, we have also noticed that the charged residues Asp22 and Lys24 (or Arg24 in mice) at the tip of AB loop of pT&#x003B1;, which were reportedly involved in pre-TCR oligomerization (Yamasaki et al., <xref ref-type="bibr" rid="B49">2006</xref>), are located below the FG loop where the CD3 subunits may bind (Figure <xref ref-type="fig" rid="F6">6</xref>A). Mutations of Asp22 and Lys24 (or Arg24 in mice) may alter pre-TCR signaling and/or internalization through modulating effects of CD3-related activation. That being said, whether the CD3 heterodimers are oriented near the C&#x003B2; FG loop (Figure <xref ref-type="fig" rid="F6">6</xref>A) exactly as in the mature TCR complex, or alternatively, that juxtaposition is modified remains to be determined.</p>
<p>In the report by Pang et al., <xref ref-type="bibr" rid="B33">2010</xref>, the authors have provided some experimental evidences, including site-directed mutagenesis, supporting their pre-TCR dimeric model. They demonstrated that three mutations, namely Y35&#x003B2;A, F108&#x003B2;A, and W46&#x003B1;R, affect pre-TCR cell surface expression. It is particularly intriguing that mutation Y35A in the TCR&#x003B2; completely abrogate cell surface expression of the pre-TCR, but did not affect LC13 &#x003B1;&#x003B2;TCR cell surface expression (Pang et al., <xref ref-type="bibr" rid="B33">2010</xref>). As discussed above, Tyr35 may be involved in hydrogen-bonding to main chain atom of Gln106 to facilitate dimer formation for the &#x003B2;&#x003B2; homodimer in the pre-TCR as well as the &#x003B1;&#x003B2;TCR heterodimer. Given that in the case of &#x003B1;&#x003B2;TCR, there are many more hydrophilic interactions between C&#x003B1; and C&#x003B2; domains (Wang et al., <xref ref-type="bibr" rid="B45">1998</xref>), the Y35A mutation may be less detrimental than in the pre-TCR where only Tyr35 and Gln37 determine proper homodimeric orientation. On the other hand, Phe108&#x003B2; is within the critical hydrophobic patch we discussed extensively above. It is not surprising to see the lower level expression for the mutant F108&#x003B2;A on the cell surface. The effect of the W46&#x003B1;R mutation is more complicated to interprete. This Trp46 is located at the center of CFG face of pT&#x003B1; domain. In the &#x0201C;head-to-tail&#x0201D; model, this face involves contacts with V&#x003B2; domain of the dimeric partner. The W46&#x003B1;R mutation would disrupt the dimer. In our model, the pT&#x003B1;&#x02019;s CFG face is exposed. However, compared with the pT&#x003B1;&#x02019;s ABED face, the structure of this CFG face is much less regular. The residue W46&#x003B1;R&#x02019;s side chain indole ring lies flat onto the pT&#x003B1; domain, and has extensive hydrophobic interaction with nearby Pro42 on the same C strand and His92 from the F strand (Figure <xref ref-type="fig" rid="FA2">A2</xref> in Appendix). Therefore, this Trp46 may serve to stabilize the pT&#x003B1; domain and a mutation of W46R might be detrimental, impacting surface expression.</p>
<p>Whether a pre-TCR monomer&#x02013;dimer equilibrium might exist on the DN thymocyte surface with one or both structures competent for ligand-binding requires further analysis. Clearly, there is much to be resolved about the structure and function of the pre-TCR through future experimental endeavors.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>In this work, we report crystal structures of two TCR &#x003B2; subunits. In conjunction with other similar structures deposited in PDB, we have identified a conserved hydrophobic patch on the CFG face of V&#x003B2; domain that is invariably shielded from solvent exposure. In one of our TCR &#x003B2; structures, the N15&#x003B2;, a homodimer is formed between the CFG faces of the two V&#x003B2; domains. By incorporating a newly published pre-TCR structure, we propose a pre-TCR dimer model based on this N15&#x003B2; homodimer. We discuss the structural and functional advantages of this model relative to alternative models.</p>
</sec>
<sec>
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<app-group>
<app id="A1">
<title>Appendix</title>
<fig id="FA1" position="float">
<label>Figure A1</label>
<caption><p><bold>Solvent molecule HEPES intercalates in the V&#x003B2;/V&#x003B2; interface</bold>. Only two V&#x003B2; domains are shown. The side chain of Tyr35 and the main chain of Gln106 as well as the HEPES molecule are in stick model. The intercalated HEPES prevents the Tyr35 from forming a hydrogen bond to the main chain of Gln106.</p></caption>
<graphic xlink:href="fimmu-02-00005-a001.tif"/>
</fig>
<fig id="FA2" position="float">
<label>Figure A2</label>
<caption><p><bold>The CFG face of the pre-T&#x003B1; domain</bold>. The view looks down the CFG face. Trp46 is located at the center of the face. Compared with the ABE face, this face is much less regular and with shorter &#x003B2; strands. The side chain indole ring of Trp46 lie flat on the domain, and has hydrophobic contacts with Pro42 and His92, which may help stabilize the domain.</p></caption>
<graphic xlink:href="fimmu-02-00005-a002.tif"/>
</fig>
</app>
</app-group>
<ack>
<p>This work has been supported by NIH grants to Ellis L. Reinherz and Jia-Huai Wang. We thank our colleagues for helpful discussion. We also thank Rob Meijers for valuable comments.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Acuto</surname> <given-names>O.</given-names></name> <name><surname>Di Bartolo</surname> <given-names>V.</given-names></name> <name><surname>Michel</surname> <given-names>F.</given-names></name></person-group> (<year>2008</year>). <article-title>Tailoring T-cell receptor signals by proximal negative feedback mechanisms</article-title>. <source>Nat. Rev. Immunol.</source> <volume>8</volume>, <fpage>699</fpage>&#x02013;<lpage>712</lpage>.<pub-id pub-id-type="pmid">18728635</pub-id></citation></ref>
<ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname> <given-names>P. D.</given-names></name> <name><surname>Afonine</surname> <given-names>P. V.</given-names></name> <name><surname>Bunkoczi</surname> <given-names>G.</given-names></name> <name><surname>Chen</surname> <given-names>V. B.</given-names></name> <name><surname>Davis</surname> <given-names>I. W.</given-names></name> <name><surname>Echols</surname> <given-names>N.</given-names></name> <name><surname>Headd</surname> <given-names>J. J.</given-names></name> <name><surname>Hung</surname> <given-names>L. W.</given-names></name> <name><surname>Kapral</surname> <given-names>G. J.</given-names></name> <name><surname>Grosse-Kunstleve</surname> <given-names>R. W.</given-names></name> <name><surname>McCoy</surname> <given-names>A. J.</given-names></name> <name><surname>Moriarty</surname> <given-names>N. W.</given-names></name> <name><surname>Oeffner</surname> <given-names>R.</given-names></name> <name><surname>Read</surname> <given-names>R. J.</given-names></name> <name><surname>Richardson</surname> <given-names>D. C.</given-names></name> <name><surname>Richardson</surname> <given-names>J. S.</given-names></name> <name><surname>Terwilliger</surname> <given-names>T. C.</given-names></name> <name><surname>Zwart</surname> <given-names>P. H.</given-names></name></person-group> (<year>2010</year>). <article-title>PHENIX: a comprehensive python-based system for macromolecular structure solution</article-title>. <source>Acta Crystallogr. D Biol. Crystallogr.</source> <volume>66</volume>, <fpage>213</fpage>&#x02013;<lpage>221</lpage>.<pub-id pub-id-type="pmid">20124702</pub-id></citation></ref>
<ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Argaet</surname> <given-names>V. P.</given-names></name> <name><surname>Schmidt</surname> <given-names>C. W.</given-names></name> <name><surname>Burrows</surname> <given-names>S. R.</given-names></name> <name><surname>Silins</surname> <given-names>S. L.</given-names></name> <name><surname>Kurilla</surname> <given-names>M. G.</given-names></name> <name><surname>Doolan</surname> <given-names>D. L.</given-names></name> <name><surname>Suhrbier</surname> <given-names>A.</given-names></name> <name><surname>Moss</surname> <given-names>D. J.</given-names></name> <name><surname>Kieff</surname> <given-names>E.</given-names></name> <name><surname>Sculley</surname> <given-names>T. B.</given-names></name> <name><surname>Misko</surname> <given-names>I. S.</given-names></name></person-group> (<year>1994</year>). <article-title>Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus</article-title>. <source>J. Exp. Med.</source> <volume>180</volume>, <fpage>2335</fpage>&#x02013;<lpage>2340</lpage>.<pub-id pub-id-type="pmid">7964506</pub-id></citation></ref>
<ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ashton-Rickardt</surname> <given-names>P. G.</given-names></name></person-group> (<year>2007</year>). <article-title>Studying T-cell repertoire selection using fetal thymus organ culture</article-title>. <source>Methods Mol. Biol.</source> <volume>380</volume>, <fpage>171</fpage>&#x02013;<lpage>184</lpage>.<pub-id pub-id-type="pmid">17876093</pub-id></citation></ref>
<ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bentley</surname> <given-names>G. A.</given-names></name> <name><surname>Boulot</surname> <given-names>G.</given-names></name> <name><surname>Karjalainen</surname> <given-names>K.</given-names></name> <name><surname>Mariuzza</surname> <given-names>R. A.</given-names></name></person-group> (<year>1995</year>). <article-title>Crystal structure of the &#x003B2; chain of a T cell antigen receptor</article-title>. <source>Science</source> <volume>267</volume>, <fpage>1984</fpage>&#x02013;<lpage>1987</lpage>.<pub-id pub-id-type="doi">10.1126/science.7701320</pub-id><pub-id pub-id-type="pmid">7701320</pub-id></citation></ref>
<ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brunger</surname> <given-names>A.</given-names></name> <name><surname>Adams</surname> <given-names>P.</given-names></name> <name><surname>Clore</surname> <given-names>G.</given-names></name> <name><surname>DeLano</surname> <given-names>W.</given-names></name> <name><surname>Gros</surname> <given-names>P.</given-names></name> <name><surname>Grosse-Kunstleve</surname> <given-names>R.</given-names></name> <name><surname>Jiang</surname> <given-names>J.-S.</given-names></name> <name><surname>Kuszewski</surname> <given-names>J.</given-names></name> <name><surname>Nilges</surname> <given-names>N.</given-names></name> <name><surname>Pannu</surname> <given-names>N.</given-names></name> <name><surname>Read</surname> <given-names>R. J.</given-names></name> <name><surname>Rice</surname> <given-names>L. M.</given-names></name> <name><surname>Simonson</surname> <given-names>T.</given-names></name> <name><surname>Warren</surname> <given-names>G. L.</given-names></name></person-group> (<year>1998</year>). <article-title>Crystallography and NMR system (CNS): a new software system for macromolecular structure determination</article-title>. <source>Acta Crystallogr. D Biol. Crystallogr.</source> <volume>54</volume>, <fpage>905</fpage>&#x02013;<lpage>921</lpage>.<pub-id pub-id-type="pmid">9757107</pub-id></citation></ref>
<ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Casasnovas</surname> <given-names>J. M.</given-names></name> <name><surname>Springer</surname> <given-names>T. A.</given-names></name> <name><surname>Liu</surname> <given-names>J. H.</given-names></name> <name><surname>Harrison</surname> <given-names>S. C.</given-names></name> <name><surname>Wang</surname> <given-names>J.-H.</given-names></name></person-group> (<year>1997</year>). <article-title>Crystal structure of ICAM-2 reveals a distinctive integrin recognition surface</article-title>. <source>Nature</source> <volume>387</volume>, <fpage>312</fpage>&#x02013;<lpage>315</lpage>.<pub-id pub-id-type="doi">10.1038/387312a0</pub-id><pub-id pub-id-type="pmid">9153399</pub-id></citation></ref>
<ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname> <given-names>H. C.</given-names></name> <name><surname>Smolyar</surname> <given-names>A.</given-names></name> <name><surname>Spoerl</surname> <given-names>R.</given-names></name> <name><surname>Witte</surname> <given-names>T.</given-names></name> <name><surname>Yao</surname> <given-names>Y.</given-names></name> <name><surname>Goyarts</surname> <given-names>E. C.</given-names></name> <name><surname>Nathenson</surname> <given-names>S. G.</given-names></name> <name><surname>Reinherz</surname> <given-names>E. L.</given-names></name></person-group> (<year>1997</year>). <article-title>Topology of T cell receptor-peptide/class I MHC interaction defined by charge reversal complementation and functional analysis</article-title>. <source>J. Mol. Biol.</source> <volume>271</volume>, <fpage>278</fpage>&#x02013;<lpage>293</lpage>.<pub-id pub-id-type="pmid">9268659</pub-id></citation></ref>
<ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname> <given-names>S.</given-names></name> <name><surname>Swaminathan</surname> <given-names>C. P.</given-names></name> <name><surname>Yang</surname> <given-names>J.</given-names></name> <name><surname>Kerzic</surname> <given-names>M. C.</given-names></name> <name><surname>Guan</surname> <given-names>R.</given-names></name> <name><surname>Kieke</surname> <given-names>M. C.</given-names></name> <name><surname>Kranz</surname> <given-names>D. M.</given-names></name> <name><surname>Mariuzza</surname> <given-names>R. A.</given-names></name> <name><surname>Sundberg</surname> <given-names>E. J.</given-names></name></person-group> (<year>2005</year>). <article-title>Structural basis of affinity maturation and intramolecular cooperativity in a protein-protein interaction</article-title>. <source>Structure</source> <volume>13</volume>, <fpage>1775</fpage>&#x02013;<lpage>1787</lpage>.<pub-id pub-id-type="doi">10.1016/j.str.2005.08.015</pub-id><pub-id pub-id-type="pmid">16338406</pub-id></citation></ref>
<ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chothia</surname> <given-names>C.</given-names></name> <name><surname>Boswell</surname> <given-names>D. R.</given-names></name> <name><surname>Lesk</surname> <given-names>A. M.</given-names></name></person-group> (<year>1988</year>). <article-title>The outline structure of the T cell &#x003B1;&#x003B2; receptor</article-title>. <source>EMBO J.</source> <volume>7</volume>, <fpage>3745</fpage>&#x02013;<lpage>3755</lpage>.<pub-id pub-id-type="pmid">3208747</pub-id></citation></ref>
<ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chothia</surname> <given-names>C.</given-names></name> <name><surname>Gelfand</surname> <given-names>I.</given-names></name> <name><surname>Kister</surname> <given-names>A.</given-names></name></person-group> (<year>1998</year>). <article-title>Structural determinants in the sequences of immunoglobulin variable domain</article-title>. <source>J. Mol. Biol.</source> <volume>278</volume>, <fpage>457</fpage>&#x02013;<lpage>479</lpage>.<pub-id pub-id-type="pmid">9571064</pub-id></citation></ref>
<ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname> <given-names>I. W.</given-names></name> <name><surname>Leaver-Fay</surname> <given-names>A.</given-names></name> <name><surname>Chen</surname> <given-names>V. B.</given-names></name> <name><surname>Block</surname> <given-names>J. N.</given-names></name> <name><surname>Kapral</surname> <given-names>G. J.</given-names></name> <name><surname>Wang</surname> <given-names>X.</given-names></name> <name><surname>Murray</surname> <given-names>L. W.</given-names></name> <name><surname>Arendall</surname> <given-names>W. B.</given-names> <suffix>III</suffix></name> <name><surname>Snoeyink</surname> <given-names>J.</given-names></name> <name><surname>Richardson</surname> <given-names>J. S.</given-names></name> <name><surname>Richardson</surname> <given-names>D. C.</given-names></name></person-group> (<year>2007</year>). <article-title>MolProbity: all-atom contacts and structure validation for proteins and nucleic acids</article-title>. <source>Nucleic Acids Res.</source> <volume>35</volume>, <fpage>W375</fpage>&#x02013;<lpage>W383</lpage>.<pub-id pub-id-type="pmid">17452350</pub-id></citation></ref>
<ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Desmyter</surname> <given-names>A.</given-names></name> <name><surname>Transue</surname> <given-names>T. R.</given-names></name> <name><surname>Ghahroudi</surname> <given-names>M. A.</given-names></name> <name><surname>Thi</surname> <given-names>M. H.</given-names></name> <name><surname>Poortmans</surname> <given-names>F.</given-names></name> <name><surname>Hamers</surname> <given-names>R.</given-names></name> <name><surname>Muyldermans</surname> <given-names>S.</given-names></name> <name><surname>Wyns</surname> <given-names>L.</given-names></name></person-group> (<year>1996</year>). <article-title>Crystal structure of a camel single-domain VH antibody fragment in complex with lysozyme</article-title>. <source>Nat. Struct. Biol.</source> <volume>3</volume>, <fpage>803</fpage>&#x02013;<lpage>811</lpage>.<pub-id pub-id-type="pmid">8784355</pub-id></citation></ref>
<ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Emsley</surname> <given-names>P.</given-names></name> <name><surname>Cowtan</surname> <given-names>K.</given-names></name></person-group> (<year>2004</year>). <article-title>Coot: model-building tools for molecular graphics</article-title>. <source>Acta Crystallogr. D Biol. Crystallogr.</source> <volume>60</volume>, <fpage>2126</fpage>&#x02013;<lpage>2132</lpage>.<pub-id pub-id-type="pmid">15572765</pub-id></citation></ref>
<ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname> <given-names>D.</given-names></name> <name><surname>Bond</surname> <given-names>C. J.</given-names></name> <name><surname>Ely</surname> <given-names>L. K.</given-names></name> <name><surname>Maynard</surname> <given-names>J.</given-names></name> <name><surname>Garcia</surname> <given-names>K. C.</given-names></name></person-group> (<year>2007</year>). <article-title>Structural evidence for a germline-encoded T cell receptor-major histocompatibility complex interaction &#x0201C;codon&#x0201D;</article-title>. <source>Nat. Immunol.</source> <volume>8</volume>, <fpage>975</fpage>&#x02013;<lpage>983</lpage>.</citation></ref>
<ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fields</surname> <given-names>B. A.</given-names></name> <name><surname>Ober</surname> <given-names>B.</given-names></name> <name><surname>Malchiodi</surname> <given-names>E. L.</given-names></name> <name><surname>Lebedeva</surname> <given-names>M. I.</given-names></name> <name><surname>Braden</surname> <given-names>B. C.</given-names></name> <name><surname>Ysern</surname> <given-names>X.</given-names></name> <name><surname>Kim</surname> <given-names>J. K.</given-names></name> <name><surname>Shao</surname> <given-names>X.</given-names></name> <name><surname>Ward</surname> <given-names>E. S.</given-names></name> <name><surname>Mariuzza</surname> <given-names>R. A.</given-names></name></person-group> (<year>1995</year>). <article-title>Crystal structure of the V&#x003B1; domain of a T cell antigen receptor</article-title>. <source>Science</source> <volume>270</volume>, <fpage>1821</fpage>&#x02013;<lpage>1824</lpage>.<pub-id pub-id-type="doi">10.1126/science.270.5243.1821</pub-id><pub-id pub-id-type="pmid">8525376</pub-id></citation></ref>
<ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fields</surname> <given-names>B. A.</given-names></name> <name><surname>Ysern</surname> <given-names>X.</given-names></name> <name><surname>Poljak</surname> <given-names>R. J.</given-names></name> <name><surname>Shao</surname> <given-names>X.</given-names></name> <name><surname>Ward</surname> <given-names>E. S.</given-names></name> <name><surname>Mariuzza</surname> <given-names>R. A.</given-names></name></person-group> (<year>1994</year>). <article-title>Crystallization and preliminary X-ray diffraction study of a bacterially produced T-cell antigen receptor V&#x003B1; domain</article-title>. <source>J. Mol. Biol.</source> <volume>239</volume>, <fpage>339</fpage>&#x02013;<lpage>341</lpage>.<pub-id pub-id-type="pmid">7515113</pub-id></citation></ref>
<ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gallegos</surname> <given-names>A. M.</given-names></name> <name><surname>Bevan</surname> <given-names>M. J.</given-names></name></person-group> (<year>2006</year>). <article-title>Central tolerance: good but imperfect</article-title>. <source>Immunol. Rev.</source> <volume>209</volume>, <fpage>290</fpage>&#x02013;<lpage>296</lpage>.<pub-id pub-id-type="pmid">16448550</pub-id></citation></ref>
<ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ghendler</surname> <given-names>Y.</given-names></name> <name><surname>Teng</surname> <given-names>M. K.</given-names></name> <name><surname>Liu</surname> <given-names>J. H.</given-names></name> <name><surname>Witte</surname> <given-names>T.</given-names></name> <name><surname>Liu</surname> <given-names>J.</given-names></name> <name><surname>Kim</surname> <given-names>K. S.</given-names></name> <name><surname>Kern</surname> <given-names>P.</given-names></name> <name><surname>Chang</surname> <given-names>H. C.</given-names></name> <name><surname>Wang</surname> <given-names>J. H.</given-names></name> <name><surname>Reinherz</surname> <given-names>E. L.</given-names></name></person-group> (<year>1998</year>). <article-title>Differential thymic selection outcomes stimulated by focal structural alteration in peptide/major histocompatibility complex ligands</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>95</volume>, <fpage>10061</fpage>&#x02013;<lpage>10066</lpage>.<pub-id pub-id-type="pmid">9707600</pub-id></citation></ref>
<ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Goyarts</surname> <given-names>E. C.</given-names></name> <name><surname>Vegh</surname> <given-names>Z.</given-names></name> <name><surname>Kalergis</surname> <given-names>A. M.</given-names></name> <name><surname>Horig</surname> <given-names>H.</given-names></name> <name><surname>Papadopoulos</surname> <given-names>N. J.</given-names></name> <name><surname>Young</surname> <given-names>A. C.</given-names></name> <name><surname>Thomson</surname> <given-names>C. T.</given-names></name> <name><surname>Chang</surname> <given-names>H. C.</given-names></name> <name><surname>Joyce</surname> <given-names>S.</given-names></name> <name><surname>Nathenson</surname> <given-names>S. G.</given-names></name></person-group> (<year>1998</year>). <article-title>Point mutations in the &#x003B2; chain CDR3 can alter the T cell receptor recognition pattern on an MHC class I/peptide complex over a broad interface area</article-title>. <source>Mol. Immunol.</source> <volume>35</volume>, <fpage>593</fpage>&#x02013;<lpage>607</lpage>.<pub-id pub-id-type="pmid">9823758</pub-id></citation></ref>
<ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gras</surname> <given-names>S.</given-names></name> <name><surname>Burrows</surname> <given-names>S. R.</given-names></name> <name><surname>Kjer-Nielsen</surname> <given-names>L.</given-names></name> <name><surname>Clements</surname> <given-names>C. S.</given-names></name> <name><surname>Liu</surname> <given-names>Y. C.</given-names></name> <name><surname>Sullivan</surname> <given-names>L. C.</given-names></name> <name><surname>Bell</surname> <given-names>M. J.</given-names></name> <name><surname>Brooks</surname> <given-names>A. G.</given-names></name> <name><surname>Purcell</surname> <given-names>A. W.</given-names></name> <name><surname>McCluskey</surname> <given-names>J.</given-names></name> <name><surname>Rossjohn</surname> <given-names>J.</given-names></name></person-group> (<year>2009</year>). <article-title>The shaping of T cell receptor recognition by self-tolerance</article-title>. <source>Immunity</source> <volume>30</volume>, <fpage>193</fpage>&#x02013;<lpage>203</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2008.11.011</pub-id><pub-id pub-id-type="pmid">19167249</pub-id></citation></ref>
<ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Griesemer</surname> <given-names>A. D.</given-names></name> <name><surname>Sorenson</surname> <given-names>E. C.</given-names></name> <name><surname>Hardy</surname> <given-names>M. A.</given-names></name></person-group> (<year>2010</year>). <article-title>The role of the thymus in tolerance</article-title>. <source>Transplantation</source> <volume>90</volume>, <fpage>465</fpage>&#x02013;<lpage>474</lpage>.<pub-id pub-id-type="doi">10.1097/TP.0b013e3181e7e54f</pub-id><pub-id pub-id-type="pmid">20555306</pub-id></citation></ref>
<ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Haks</surname> <given-names>M. C.</given-names></name> <name><surname>Pepin</surname> <given-names>E.</given-names></name> <name><surname>van den Brakel</surname> <given-names>J. H. N.</given-names></name> <name><surname>Smeele</surname> <given-names>S. A. A.</given-names></name> <name><surname>Belkowski</surname> <given-names>S. M.</given-names></name> <name><surname>Kessels</surname> <given-names>H. W. H. G.</given-names></name> <name><surname>Krimpenfort</surname> <given-names>P.</given-names></name> <name><surname>Kruisbeek</surname> <given-names>A. M.</given-names></name></person-group> (<year>2002</year>). <article-title>Contribution of the T cell receptor-associated CD3&#x00393;-ITAM to thymocyte selection</article-title>. <source>J. Exp. Med.</source> <volume>196</volume>, <fpage>1</fpage>&#x02013;<lpage>13</lpage>.<pub-id pub-id-type="pmid">12093866</pub-id></citation></ref>
<ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ishizuka</surname> <given-names>J.</given-names></name> <name><surname>Stewart-Jones</surname> <given-names>G.</given-names></name> <name><surname>van der Merwe</surname> <given-names>A.</given-names></name> <name><surname>Bell</surname> <given-names>J.</given-names></name> <name><surname>McMichael</surname> <given-names>A.</given-names></name> <name><surname>Jones</surname> <given-names>E.</given-names></name></person-group> (<year>2008</year>). <article-title>The structural dynamics and energetics of an immunodominant T-cell receptor are programmed by its V&#x003B2; domain</article-title>. <source>Immunity</source> <volume>28</volume>, <fpage>171</fpage>&#x02013;<lpage>182</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2007.12.018</pub-id></citation></ref>
<ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Juang</surname> <given-names>J.</given-names></name> <name><surname>Ebert</surname> <given-names>P. J.</given-names></name> <name><surname>Feng</surname> <given-names>D.</given-names></name> <name><surname>Garcia</surname> <given-names>K. C.</given-names></name> <name><surname>Krogsgaard</surname> <given-names>M.</given-names></name> <name><surname>Davis</surname> <given-names>M. M.</given-names></name></person-group> (<year>2010</year>). <article-title>Peptide-MHC heterodimers show that thymic positive selection requires a more restricted set of self-peptides than negative selection</article-title>. <source>J. Exp. Med.</source> <volume>207</volume>, <fpage>1223</fpage>&#x02013;<lpage>1234</lpage>.<pub-id pub-id-type="pmid">20457759</pub-id></citation></ref>
<ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kern</surname> <given-names>P. S.</given-names></name> <name><surname>Teng</surname> <given-names>M.-K.</given-names></name> <name><surname>Smolyar</surname> <given-names>A.</given-names></name> <name><surname>Liu</surname> <given-names>J.-H.</given-names></name> <name><surname>Liu</surname> <given-names>J.</given-names></name> <name><surname>Hussey</surname> <given-names>R. E.</given-names></name> <name><surname>Spoerl</surname> <given-names>R.</given-names></name> <name><surname>Chang</surname> <given-names>H.-C.</given-names></name> <name><surname>Reinherz</surname> <given-names>E. L.</given-names></name> <name><surname>Wang</surname> <given-names>J.-H.</given-names></name></person-group> (<year>1998</year>). <article-title>Structural basis of CD8 co-receptor function revealed by crystallographic analysis of a nurine CD8&#x003B1;&#x003B1; ectodomain fragment in complex with H-2Kb</article-title>. <source>Immunity</source> <volume>9</volume>, <fpage>519</fpage>&#x02013;<lpage>530</lpage>.<pub-id pub-id-type="doi">10.1016/S1074-7613(00)80635-4</pub-id><pub-id pub-id-type="pmid">9806638</pub-id></citation></ref>
<ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>S. T.</given-names></name> <name><surname>Takeuchi</surname> <given-names>K.</given-names></name> <name><surname>Sun</surname> <given-names>Z. Y.</given-names></name> <name><surname>Touma</surname> <given-names>M.</given-names></name> <name><surname>Castro</surname> <given-names>C. E.</given-names></name> <name><surname>Fahmy</surname> <given-names>A.</given-names></name> <name><surname>Lang</surname> <given-names>M. J.</given-names></name> <name><surname>Wagner</surname> <given-names>G.</given-names></name> <name><surname>Reinherz</surname> <given-names>E. L.</given-names></name></person-group> (<year>2009</year>). <article-title>The &#x003B1;&#x003B2; T cell receptor is an anisotropic mechanosensor</article-title>. <source>J. Biol. Chem.</source> <volume>284</volume>, <fpage>31028</fpage>&#x02013;<lpage>31037</lpage>.<pub-id pub-id-type="pmid">19755427</pub-id></citation></ref>
<ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kuhns</surname> <given-names>M. S.</given-names></name> <name><surname>Girvin</surname> <given-names>A. T.</given-names></name> <name><surname>Klein</surname> <given-names>L. O.</given-names></name> <name><surname>Chen</surname> <given-names>R.</given-names></name> <name><surname>Jensen</surname> <given-names>K. D.</given-names></name> <name><surname>Newell</surname> <given-names>E. W.</given-names></name> <name><surname>Huppa</surname> <given-names>J. B.</given-names></name> <name><surname>Lillemeier</surname> <given-names>B. F.</given-names></name> <name><surname>Huse</surname> <given-names>M.</given-names></name> <name><surname>Chien</surname> <given-names>Y. H.</given-names></name> <name><surname>Garcia</surname> <given-names>K. C.</given-names></name> <name><surname>Davis</surname> <given-names>M. M.</given-names></name></person-group> (<year>2010</year>). <article-title>Evidence for a functional sidedness to the &#x003B1;&#x003B2; TCR</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>107</volume>, <fpage>5094</fpage>&#x02013;<lpage>5099</lpage>.<pub-id pub-id-type="pmid">20202921</pub-id></citation></ref>
<ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lawrence</surname> <given-names>M. C.</given-names></name> <name><surname>Colman</surname> <given-names>P. M.</given-names></name></person-group> (<year>1993</year>). <article-title>Shape complementarity at protein/protein interfaces</article-title>. <source>J. Mol. Biol.</source> <volume>234</volume>, <fpage>946</fpage>&#x02013;<lpage>950</lpage>.<pub-id pub-id-type="pmid">8263940</pub-id></citation></ref>
<ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>H.</given-names></name> <name><surname>Lebedeva</surname> <given-names>M. I.</given-names></name> <name><surname>Ward</surname> <given-names>E. S.</given-names></name> <name><surname>Mariuzza</surname> <given-names>R. A.</given-names></name></person-group> (<year>1997</year>). <article-title>Dual conformations of a T cell receptor V&#x003B1; homodimer: implications for variability in V&#x003B1; V&#x003B2; domain association</article-title>. <source>J. Mol. Biol.</source> <volume>269</volume>, <fpage>385</fpage>&#x02013;<lpage>394</lpage>.<pub-id pub-id-type="pmid">9199407</pub-id></citation></ref>
<ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Love</surname> <given-names>P. E.</given-names></name> <name><surname>Lee</surname> <given-names>J.</given-names></name> <name><surname>Shores</surname> <given-names>E. W.</given-names></name></person-group> (<year>2000</year>). <article-title>Critical relationship between TCR signaling potential and TCR affinity during thymocyte selection</article-title>. <source>J. Immunol.</source> <volume>165</volume>, <fpage>3080</fpage>&#x02013;<lpage>3087</lpage>.<pub-id pub-id-type="pmid">10975819</pub-id></citation></ref>
<ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mariathasan</surname> <given-names>S.</given-names></name> <name><surname>Jones</surname> <given-names>R. G.</given-names></name> <name><surname>Ohashi</surname> <given-names>P. S.</given-names></name></person-group> (<year>1999</year>). <article-title>Signals involved in thymocyte positive and negative selection</article-title>. <source>Semin. Immunol.</source> <volume>11</volume>, <fpage>263</fpage>&#x02013;<lpage>272</lpage>.<pub-id pub-id-type="pmid">10441212</pub-id></citation></ref>
<ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pang</surname> <given-names>S. S.</given-names></name> <name><surname>Berry</surname> <given-names>R.</given-names></name> <name><surname>Chen</surname> <given-names>Z.</given-names></name> <name><surname>Kjer-Nielsen</surname> <given-names>L.</given-names></name> <name><surname>Perugini</surname> <given-names>M. A.</given-names></name> <name><surname>King</surname> <given-names>G. F.</given-names></name> <name><surname>Wang</surname> <given-names>C.</given-names></name> <name><surname>Chew</surname> <given-names>S. H.</given-names></name> <name><surname>La Gruta</surname> <given-names>N. L.</given-names></name> <name><surname>Williams</surname> <given-names>N. K.</given-names></name> <name><surname>Beddoe</surname> <given-names>T.</given-names></name> <name><surname>Tiganis</surname> <given-names>T.</given-names></name> <name><surname>Cowieson</surname> <given-names>N. P.</given-names></name> <name><surname>Godfrey</surname> <given-names>D. I.</given-names></name> <name><surname>Purcell</surname> <given-names>A. W.</given-names></name> <name><surname>Wilce</surname> <given-names>M. C.</given-names></name> <name><surname>McCluskey</surname> <given-names>J.</given-names></name> <name><surname>Rossjohn</surname> <given-names>J.</given-names></name></person-group> (<year>2010</year>). <article-title>The structural basis for autonomous dimerization of the pre-T-cell antigen receptor</article-title>. <source>Nature</source> <volume>467</volume>, <fpage>844</fpage>&#x02013;<lpage>848</lpage>.<pub-id pub-id-type="doi">10.1038/nature09448</pub-id><pub-id pub-id-type="pmid">20944746</pub-id></citation></ref>
<ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rudolph</surname> <given-names>M. G.</given-names></name> <name><surname>Stanfield</surname> <given-names>R. L.</given-names></name> <name><surname>Wilson</surname> <given-names>I. A.</given-names></name></person-group> (<year>2006</year>). <article-title>How TCRs bind MHCs, peptides, and coreceptors</article-title>. <source>Annu. Rev. Immunol.</source> <volume>24</volume>, <fpage>419</fpage>&#x02013;<lpage>466</lpage>.<pub-id pub-id-type="doi">10.1146/annurev.immunol.23.021704.115658</pub-id><pub-id pub-id-type="pmid">16551255</pub-id></citation></ref>
<ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Scott-Browne</surname> <given-names>J. P.</given-names></name> <name><surname>White</surname> <given-names>J.</given-names></name> <name><surname>Kappler</surname> <given-names>J. W.</given-names></name> <name><surname>Gapin</surname> <given-names>L.</given-names></name> <name><surname>Marrack</surname> <given-names>P.</given-names></name></person-group> (<year>2009</year>). <article-title>Germline-encoded amino acids in the &#x003B1;&#x003B2;T-cell receptor control thymic selection</article-title>. <source>Nature</source> <volume>458</volume>, <fpage>1043</fpage>&#x02013;<lpage>1046</lpage>.<pub-id pub-id-type="doi">10.1038/nature07812</pub-id><pub-id pub-id-type="pmid">19262510</pub-id></citation></ref>
<ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shinkai</surname> <given-names>Y.</given-names></name> <name><surname>Koyasu</surname> <given-names>S.</given-names></name> <name><surname>Nakayama</surname> <given-names>K.</given-names></name> <name><surname>Murphy</surname> <given-names>K. M.</given-names></name> <name><surname>Loh</surname> <given-names>D. Y.</given-names></name> <name><surname>Reinherz</surname> <given-names>E. L.</given-names></name> <name><surname>Alt</surname> <given-names>F. W.</given-names></name></person-group> (<year>1993</year>). <article-title>Restoration of T cell development in RAG-2-deficient mice by functional TCR transgenes</article-title>. <source>Science</source> <volume>259</volume>, <fpage>822</fpage>&#x02013;<lpage>825</lpage>.<pub-id pub-id-type="doi">10.1126/science.8430336</pub-id><pub-id pub-id-type="pmid">8430336</pub-id></citation></ref>
<ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smith-Garvin</surname> <given-names>J. E.</given-names></name> <name><surname>Koretzky</surname> <given-names>G. A.</given-names></name> <name><surname>Jordan</surname> <given-names>M. S.</given-names></name></person-group> (<year>2009</year>). <article-title>T cell activation</article-title>. <source>Annu. Rev. Immunol.</source> <volume>27</volume>, <fpage>591</fpage>&#x02013;<lpage>619</lpage>.<pub-id pub-id-type="doi">10.1146/annurev.immunol.021908.132706</pub-id><pub-id pub-id-type="pmid">19132916</pub-id></citation></ref>
<ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Starr</surname> <given-names>T. K.</given-names></name> <name><surname>Jameson</surname> <given-names>S. C.</given-names></name> <name><surname>Hogquist</surname> <given-names>K. A.</given-names></name></person-group> (<year>2003</year>). <article-title>Positive and negative selection of T cells</article-title>. <source>Annu. Rev. Immunol.</source> <volume>21</volume>, <fpage>139</fpage>&#x02013;<lpage>176</lpage>.<pub-id pub-id-type="doi">10.1146/annurev.immunol.21.120601.141107</pub-id><pub-id pub-id-type="pmid">12414722</pub-id></citation></ref>
<ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname> <given-names>Z. J.</given-names></name> <name><surname>Kim</surname> <given-names>K. S.</given-names></name> <name><surname>Wagner</surname> <given-names>G.</given-names></name> <name><surname>Reinherz</surname> <given-names>E. L.</given-names></name></person-group> (<year>2001</year>). <article-title>Mechanisms contributing to T cell receptor signaling and assembly revealed by the solution structure of an ectodomain fragment of the CD3 &#x003B5;&#x00393; heterodimer</article-title>. <source>Cell</source> <volume>105</volume>, <fpage>913</fpage>&#x02013;<lpage>923</lpage>.<pub-id pub-id-type="doi">10.1016/S0092-8674(01)00395-6</pub-id><pub-id pub-id-type="pmid">11439187</pub-id></citation></ref>
<ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname> <given-names>Z. Y.</given-names></name> <name><surname>Kim</surname> <given-names>S. T.</given-names></name> <name><surname>Kim</surname> <given-names>I. C.</given-names></name> <name><surname>Fahmy</surname> <given-names>A.</given-names></name> <name><surname>Reinherz</surname> <given-names>E. L.</given-names></name> <name><surname>Wagner</surname> <given-names>G.</given-names></name></person-group> (<year>2004</year>). <article-title>Solution structure of the CD3&#x003B5;&#x003B4; ectodomain and comparison with CD3&#x003B5;&#x00393; as a basis for modeling T cell receptor topology and signaling</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>101</volume>, <fpage>16867</fpage>&#x02013;<lpage>16872</lpage>.<pub-id pub-id-type="pmid">15557001</pub-id></citation></ref>
<ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vagin</surname> <given-names>A. A.</given-names></name> <name><surname>Steiner</surname> <given-names>R. A.</given-names></name> <name><surname>Lebedev</surname> <given-names>A. A.</given-names></name> <name><surname>Potterton</surname> <given-names>L.</given-names></name> <name><surname>McNicholas</surname> <given-names>S.</given-names></name> <name><surname>Long</surname> <given-names>F.</given-names></name> <name><surname>Murshudov</surname> <given-names>G. N.</given-names></name></person-group> (<year>2004</year>). <article-title>REFMAC5 dictionary: organization of prior chemical knowledge and guidelines for its use</article-title>. <source>Acta Crystallogr. D Biol. Crystallogr.</source> <volume>60</volume>, <fpage>2184</fpage>&#x02013;<lpage>2195</lpage>.<pub-id pub-id-type="pmid">15572771</pub-id></citation></ref>
<ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>van der Merwe</surname> <given-names>P. A.</given-names></name> <name><surname>Davis</surname> <given-names>S. J.</given-names></name></person-group> (<year>2003</year>). <article-title>Molecular interactions mediating T cell antigen recognition</article-title>. <source>Annu. Rev. Immunol.</source> <volume>21</volume>, <fpage>659</fpage>&#x02013;<lpage>684</lpage>.<pub-id pub-id-type="doi">10.1146/annurev.immunol.21.120601.141036</pub-id><pub-id pub-id-type="pmid">12615890</pub-id></citation></ref>
<ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Von Boehmer</surname> <given-names>H.</given-names></name> <name><surname>Aifantis</surname> <given-names>I.</given-names></name> <name><surname>Gounari</surname> <given-names>F.</given-names></name> <name><surname>Azogui</surname> <given-names>O.</given-names></name> <name><surname>Haughn</surname> <given-names>L.</given-names></name> <name><surname>Apostolou</surname> <given-names>I.</given-names></name> <name><surname>Jaeckel</surname> <given-names>E.</given-names></name> <name><surname>Grassi</surname> <given-names>F.</given-names></name> <name><surname>Klein</surname> <given-names>L.</given-names></name></person-group> (<year>2003</year>). <article-title>Thymic selection revisited: how essential is it?</article-title> <source>Immunol. Rev.</source> <volume>191</volume>, <fpage>62</fpage>&#x02013;<lpage>78</lpage>.<pub-id pub-id-type="pmid">12614352</pub-id></citation></ref>
<ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>J.</given-names></name></person-group> (<year>2002</year>). <article-title>Protein recognition by cell surface receptors: physiological receptors versus virus interactions</article-title>. <source>Trends Biochem. Sci.</source> <volume>27</volume>, <fpage>122</fpage>&#x02013;<lpage>126</lpage>.<pub-id pub-id-type="pmid">11893508</pub-id></citation></ref>
<ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>J.-H.</given-names></name> <name><surname>Lim</surname> <given-names>K.</given-names></name> <name><surname>Smolyar</surname> <given-names>A.</given-names></name> <name><surname>Teng</surname> <given-names>M.</given-names></name> <name><surname>Liu</surname> <given-names>J.</given-names></name> <name><surname>Tse</surname> <given-names>A. G.</given-names></name> <name><surname>Hussey</surname> <given-names>R. E.</given-names></name> <name><surname>Chishti</surname> <given-names>Y.</given-names></name> <name><surname>Thomson</surname> <given-names>C. T.</given-names></name> <name><surname>Sweet</surname> <given-names>R. M.</given-names></name> <name><surname>Nathenson</surname> <given-names>S. G.</given-names></name> <name><surname>Chang</surname> <given-names>H. C.</given-names></name> <name><surname>Sacchettini</surname> <given-names>J. C.</given-names></name> <name><surname>Reinherz</surname> <given-names>E. L.</given-names></name></person-group> (<year>1998</year>). <article-title>Atomic structure of an &#x003B1;&#x003B2; T cell receptor (TCR) heterodimer in complex with an anti-TCR fab fragment derived from a mitogenic antibody</article-title>. <source>EMBO J.</source> <volume>17</volume>, <fpage>10</fpage>&#x02013;<lpage>26</lpage>.<pub-id pub-id-type="doi">10.1093/emboj/17.1.10</pub-id><pub-id pub-id-type="pmid">9427737</pub-id></citation></ref>
<ref id="B46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>J. H.</given-names></name> <name><surname>Mallis</surname> <given-names>R. J.</given-names></name> <name><surname>Reinherz</surname> <given-names>E. L.</given-names></name></person-group> (<year>2008</year>). <article-title>Immunodominant-peptide recognition: beta testing TCR&#x003B1;&#x003B2;</article-title>. <source>Immunity</source> <volume>28</volume>, <fpage>139</fpage>&#x02013;<lpage>141</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2008.01.007</pub-id><pub-id pub-id-type="pmid">18275824</pub-id></citation></ref>
<ref id="B47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>J.-H.</given-names></name> <name><surname>Smolyar</surname> <given-names>A.</given-names></name> <name><surname>Tan</surname> <given-names>K.</given-names></name> <name><surname>Liu</surname> <given-names>J.-H.</given-names></name> <name><surname>Kim</surname> <given-names>M.</given-names></name> <name><surname>Sun</surname> <given-names>Z.-Y. J.</given-names></name> <name><surname>Wagner</surname> <given-names>G.</given-names></name> <name><surname>Reinherz</surname> <given-names>E. L.</given-names></name></person-group> (<year>1999</year>). <article-title>Structure of a heterophilic adhesion complex between human CD2 and CD58 (LFA-3) counter-receptors</article-title>. <source>Cell</source> <volume>97</volume>, <fpage>791</fpage>&#x02013;<lpage>803</lpage>.<pub-id pub-id-type="doi">10.1016/S0092-8674(00)80790-4</pub-id><pub-id pub-id-type="pmid">10380930</pub-id></citation></ref>
<ref id="B48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ward</surname> <given-names>E. S.</given-names></name> <name><surname>Gussow</surname> <given-names>D.</given-names></name> <name><surname>Griffiths</surname> <given-names>A. D.</given-names></name> <name><surname>Jones</surname> <given-names>P. T.</given-names></name> <name><surname>Winter</surname> <given-names>G.</given-names></name></person-group> (<year>1989</year>). <article-title>Binding activities of a repertoire of single immunoglobulin variable domains secreted from <italic>Escherichia coli</italic></article-title>. <source>Nature</source> <volume>341</volume>, <fpage>544</fpage>&#x02013;<lpage>546</lpage>.<pub-id pub-id-type="doi">10.1038/341544a0</pub-id></citation></ref>
<ref id="B49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yamasaki</surname> <given-names>S.</given-names></name> <name><surname>Ishikawa</surname> <given-names>E.</given-names></name> <name><surname>Sakuma</surname> <given-names>M.</given-names></name> <name><surname>Ogata</surname> <given-names>K.</given-names></name> <name><surname>Sakata-Sogawa</surname> <given-names>K.</given-names></name> <name><surname>Hiroshima</surname> <given-names>M.</given-names></name> <name><surname>Wiest</surname> <given-names>D. L.</given-names></name> <name><surname>Tokunaga</surname> <given-names>M.</given-names></name> <name><surname>Saito</surname> <given-names>T.</given-names></name></person-group> (<year>2006</year>). <article-title>Mechanistic basis of pre-T cell receptor-mediated autonomous signaling critical for thymocyte development</article-title>. <source>Nat. Immunol.</source> <volume>7</volume>, <fpage>67</fpage>&#x02013;<lpage>75</lpage>.<pub-id pub-id-type="pmid">16327787</pub-id></citation></ref>
<ref id="B50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yamasaki</surname> <given-names>S.</given-names></name> <name><surname>Saito</surname> <given-names>T.</given-names></name></person-group> (<year>2007</year>). <article-title>Molecular basis for pre-TCR-mediated autonomous signaling</article-title>. <source>Trends Immunol.</source> <volume>28</volume>, <fpage>39</fpage>&#x02013;<lpage>43</lpage>.<pub-id pub-id-type="doi">10.1016/j.it.2006.11.006</pub-id><pub-id pub-id-type="pmid">17126602</pub-id></citation></ref>
<ref id="B51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhong</surname> <given-names>W.</given-names></name> <name><surname>Dixit</surname> <given-names>S. B.</given-names></name> <name><surname>Mallis</surname> <given-names>R. J.</given-names></name> <name><surname>Arthanari</surname> <given-names>H.</given-names></name> <name><surname>Lugovskoy</surname> <given-names>A. A.</given-names></name> <name><surname>Beveridge</surname> <given-names>D. L.</given-names></name> <name><surname>Wagner</surname> <given-names>G.</given-names></name> <name><surname>Reinherz</surname> <given-names>E. L.</given-names></name></person-group> (<year>2007</year>). <article-title>CTL recognition of a protective immunodominant influenza A virus nucleoprotein epitope utilizes a highly restricted V&#x003B2; but diverse V&#x003B1; repertoire: functional and structural implications</article-title>. <source>J. Mol. Biol.</source> <volume>372</volume>, <fpage>535</fpage>&#x02013;<lpage>548</lpage>.<pub-id pub-id-type="pmid">17658550</pub-id></citation></ref>
<ref id="B52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhong</surname> <given-names>W.</given-names></name> <name><surname>Reinherz</surname> <given-names>E. L.</given-names></name></person-group> (<year>2004</year>). <article-title>In vivo selection of a TCR V&#x003B2; repertoire directed against an immunodominant influenza virus CTL epitope</article-title>. <source>Int. Immunol.</source> <volume>16</volume>, <fpage>1549</fpage>&#x02013;<lpage>1559</lpage>.<pub-id pub-id-type="pmid">15351787</pub-id></citation></ref>
</ref-list>
</back>
</article>
